000 01705 a2200409 4500
005 20250516011939.0
264 0 _c20111102
008 201111s 0 0 eng d
022 _a1433-2965
024 7 _a10.1007/s00198-010-1411-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeaupre, L A
245 0 0 _aOral bisphosphonates are associated with reduced mortality after hip fracture.
_h[electronic resource]
260 _bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_cMar 2011
300 _a983-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHip Fractures
_xmortality
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aOsteoporotic Fractures
_xmortality
650 0 4 _aProspective Studies
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aMorrish, D W
700 1 _aHanley, D A
700 1 _aMaksymowych, W P
700 1 _aBell, N R
700 1 _aJuby, A G
700 1 _aMajumdar, S R
773 0 _tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_gvol. 22
_gno. 3
_gp. 983-91
856 4 0 _uhttps://doi.org/10.1007/s00198-010-1411-2
_zAvailable from publisher's website
999 _c20351615
_d20351615